1 序文
2 範囲と方法論
2.1 本調査の目的
2.2 利害関係者
2.3 データソース
2.3.1 一次情報源
2.3.2 二次情報源
2.4 市場推定
2.4.1 ボトムアップアプローチ
2.4.2 トップダウンアプローチ
2.5 予測方法論
3 エグゼクティブサマリー
4 はじめに
4.1 概要
4.2 主要産業動向
5 世界の目薬＆潤滑剤市場
5.1 市場概要
5.2 市場実績
5.3 COVID-19 の影響
5.4 市場予測
6 種類別市場内訳
6.1 抗生物質
6.1.1 市場動向
6.1.2 市場予測
6.2 ホルモン
6.2.1 市場動向
6.2.2 市場予測
6.3 人工涙液
6.3.1 市場動向
6.3.2 市場予測
6.4 その他
6.4.1 市場動向
6.4.2 市場予測
7 用途別市場
7.1 眼疾患
7.1.1 市場動向
7.1.2 主な区分
7.1.2.1 ドライアイ
7.1.2.2 緑内障
7.1.2.3 結膜炎
7.1.2.4 屈折異常
7.1.2.5 その他
7.1.3 市場予測
7.2 眼科医療
7.2.1 市場動向
7.2.2 市場予測
8 地域別市場内訳
8.1 北米
8.1.1 米国
8.1.1.1 市場動向
8.1.1.2 市場予測
8.1.2 カナダ
8.1.2.1 市場動向
8.1.2.2 市場予測
8.2 アジア太平洋地域
8.2.1 中国
8.2.1.1 市場動向
8.2.1.2 市場予測
8.2.2 日本
8.2.2.1 市場動向
8.2.2.2 市場予測
8.2.3 インド
8.2.3.1 市場動向
8.2.3.2 市場予測
8.2.4 韓国
8.2.4.1 市場動向
8.2.4.2 市場予測
8.2.5 オーストラリア
8.2.5.1 市場動向
8.2.5.2 市場予測
8.2.6 インドネシア
8.2.6.1 市場動向
8.2.6.2 市場予測
8.2.7 その他
8.2.7.1 市場動向
8.2.7.2 市場予測
8.3 欧州
8.3.1 ドイツ
8.3.1.1 市場動向
8.3.1.2 市場予測
8.3.2 フランス
8.3.2.1 市場動向
8.3.2.2 市場予測
8.3.3 英国
8.3.3.1 市場動向
8.3.3.2 市場予測
8.3.4 イタリア
8.3.4.1 市場動向
8.3.4.2 市場予測
8.3.5 スペイン
8.3.5.1 市場動向
8.3.5.2 市場予測
8.3.6 ロシア
8.3.6.1 市場動向
8.3.6.2 市場予測
8.3.7 その他
8.3.7.1 市場動向
8.3.7.2 市場予測
8.4 ラテンアメリカ
8.4.1 ブラジル
8.4.1.1 市場動向
8.4.1.2 市場予測
8.4.2 メキシコ
8.4.2.1 市場動向
8.4.2.2 市場予測
8.4.3 その他
8.4.3.1 市場動向
8.4.3.2 市場予測
8.5 中東およびアフリカ
8.5.1 市場動向
8.5.2 国別の市場内訳
8.5.3 市場予測
9 推進要因、阻害要因、および機会
9.1 概要
9.2 推進要因
9.3 阻害要因
9.4 機会
10 バリューチェーン分析
11 ポーターのファイブフォース分析
11.1 概要
11.2 買い手の交渉力
11.3 供給業者の交渉力
11.4 競争の度合い
11.5 新規参入の脅威
11.6 代替品の脅威
12 価格分析
13 競合状況
13.1 市場構造
13.2 主要企業
13.3 主要企業のプロフィール
Akorn Operating Company LLC
Alcon
Allergan Plc (AbbVie Inc.)
Bausch & Lomb Incorporated
Bayer AG
Johnson & Johnson
Maya Biotech Private Limited
Prestige Consumer Healthcare Inc
Rohto Pharmaceutical Co. Ltd
Sager Pharma Kft
Similasan Corporation

The global eye drops and lubricants market size reached USD 21.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 31.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.21% during 2025-2033. The growing cases of eye disorders, rising research and development (R&D) activities in the pharmaceutical sector, and increasing popularity of hormone therapy to minimize the risks associated with dry eye syndrome are some of the major factors propelling the market.

Eye drops and lubricants are essential products used for maintaining and improving eye health. They are designed to provide relief from various eye discomforts, lubricate the eyes, and promote overall eye health. They consist of artificial tears and vasoconstrictors, which help to ease redness by constricting the blood vessels in the eyes. They are available in a variety of formulations to address specific eye conditions and symptoms. They are used to prevent dryness, redness, itchiness, and irritation caused by factors, such as dry environments, prolonged screen time, allergies, or certain medical conditions.

At present, the increasing demand for eye drops and lubricants to alleviate symptoms and provide relief from discomfort in the eyes is impelling the growth of the market. Besides this, the rising awareness about the beneficial aspects of using eye drops and lubricants and the necessity of taking proper eye care is contributing to the growth of the market. In addition, the growing popularity of hormone therapy to minimize the risks associated with dry eye syndrome is offering a favorable market outlook. Apart from this, the increasing number of open-angle glaucoma therapeutics provided via retail pharmacies is supporting the growth of the market. Additionally, the rising occurrence of various age-associated eye disorders in the geriatric population is propelling the growth of the market. Moreover, the increasing adoption of technologically advanced methods to manufacture innovative eye drops and lubricants with improved safety and efficacy is bolstering the growth of the market.

Eye Drops and Lubricants Market Trends/Drivers:
Rising cases of eye diseases

The rising prevalence of eye disorders, including dry eye syndrome, conjunctivitis, and glaucoma, is a key driver for the eye drops and lubricants market. Apart from this, prolonged digital device usage, environmental pollution, and changing lifestyles contribute to the growing incidence of these conditions. In addition, conditions like diabetes, hypertension, and obesity, which are linked to lifestyle choices and are on the rise globally, can affect eye health. For instance, diabetic retinopathy is a complication of diabetes that affects the eyes. Moreover, rapid urbanization and increased pollution are contributing to the increase in eye diseases. Exposure to air pollution is linked to conditions like dry eye syndrome and allergic conjunctivitis. As there is an increase in the occurrence of various eye disorders, the demand for eye drops and lubricants to provide relief from discomfort, itching, redness, and dryness associated with these disorders is rising around the world.

Increasing research-related activities

At present, there is an increase in the development of effective eye drops due to the growing prevalence of eye diseases caused by aging, lifestyle changes, and environmental factors. Besides this, with the advent of technology and the consequent increase in screen time, individuals are increasingly susceptible to eye strain and dryness, thereby driving the demand for innovative solutions. In addition, evolving expectations and demands of consumers are prompting researchers to seek novel formulations that provide instant relief and address the underlying causes of eye discomfort. Traditional eye drops often offer temporary relief, necessitating frequent application, and do not adequately address the root causes of dryness or provide long-lasting moisture. Consequently, the growing need for advanced formulations that can provide sustained lubrication and effectively restore the natural tear film to promote ocular comfort and health is encouraging researchers to develop efficient eye drops and lubricants.

Growing utilization of smartphones and tablets

At present, the increasing utilization of various smart devices, including smartphones, tablets, and laptops, is exerting stress on the eyes of users and raising the incidence of dry eye disease in individuals. Besides this, smartphones are equipped with high-resolution screens that emit blue light, which has a shorter wavelength and higher energy compared to other colors on the light spectrum. Excessive exposure to blue light leads to digital eye strain, also called computer vision syndrome. The constant use of smartphones, often accompanied by prolonged periods of staring at screens, exacerbates these symptoms, contributing to the rising prevalence of eye diseases. Furthermore, the excessive use of smartphones is leading to an increase in the occurrence of various eye complications and the use of various eye drops and lubricants.

Eye Drops and Lubricants Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global eye drops and lubricants market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on the type and application.

Breakup by Type:
Antibiotics
Hormones
Artificial Tears
Others

Artificial tears dominate the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes antibiotics, hormones, artificial tears, and others. According to the report, artificial tears represented the largest segment.

Artificial tears are non-prescription, over-the-counter eye drops that are used to treat symptoms associated with dry eyes. They are designed to mimic the natural tears produced by our eyes and are a blend of water, salts, and polymers that enhance viscosity and lubrication. Artificial tears provide immediate symptoms associated with dry eye syndrome, such as burning, irritation, redness, and a sensation of having something in your eyes. Artificial tears also help maintain the health and integrity of the ocular surface. By providing a surrogate for the natural tear film, they ensure the eye remains well-hydrated and nourished, reducing the risk of damage to the cornea.

Breakup by Application:

Eye Diseases
Dry Eye
Glaucoma
Conjunctivitis
Refractive Errors
Others
Eye Care

Eye diseases hold the largest share in the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes eye diseases (dry eye, glaucoma, conjunctivitis, refractive errors, and others) and eye care. According to the report, eye diseases (dry eye, glaucoma, conjunctivitis, refractive errors, and others) accounted for the largest market share.

Eye drops and lubricants are significant tools in the management and treatment of a multitude of ocular conditions. The way they help cure eye diseases is multifaceted, depending on the active ingredient in the drops and the nature of the disease. They provide symptomatic relief by mimicking the natural tear film and lubricating the ocular surface. They are also used to treat bacterial infections, such as conjunctivitis (pink eye) or corneal ulcers. These medications contain substances that inhibit the growth of bacteria or kill them outright. They function by interfering with the replication of viruses while limiting the spread of infection and speed up the healing process.

Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America exhibits a clear dominance, accounting for the largest eye drops and lubricant market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the rising occurrence of dry eye syndrome, glaucoma, age-related macular degeneration, and cataracts among the aging population. Besides this, the prolonged screen time causing digital eye strain and dry eyes among the masses is propelling the growth of the market.

Another contributing aspect is the rising occurrence of eye allergies caused by climate change and rising levels of pollution. In addition, the increasing advancement in eye care treatments is supporting the growth of the market.

Asia Pacific is estimated to expand further in this domain due to the rising utilization of smartphones and laptops to access the internet. In addition, the growing construction of eye hospitals offering efficient eyecare services is positively influencing the market.

Competitive Landscape:
Key market players are investing in research operations to innovate and improve their eye drops and lubricants. They are also focusing on developing advanced formulations, ingredients, and delivery systems to enhance the effectiveness and comfort of their products. Top companies are striving to expand their product portfolios by introducing new eye drops and lubricants that cater to different consumer needs. They are also offering specialized products for dry eye relief, allergy relief, redness reduction, contact lens lubrication, and other specific eye care concerns. Leading companies are collaborating with healthcare professionals, including ophthalmologists and optometrists, to gain insights into patient needs and develop products tailored to those needs.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Akorn Operating Company LLC
Alcon
Allergan Plc (AbbVie Inc.)
Bausch & Lomb Incorporated
Bayer AG
Johnson & Johnson
Maya Biotech Private Limited
Prestige Consumer Healthcare Inc.
Rohto Pharmaceutical Co. Ltd.
Sager Pharma Kft
Similasan Corporation

Key Questions Answered in This Report:
How has the global eye drops and lubricants market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global eye drops and lubricants market?
What is the impact of each driver, restraint, and opportunity on the global eye drops and lubricants market?
What are the key regional markets?
Which countries represent the most attractive eye drops and lubricants market?
What is the breakup of the market based on the type?
Which is the most attractive type in the eye drops and lubricants market?
What is the breakup of the market based on the application?
Which is the most attractive application in the eye drops and lubricants market?
What is the competitive structure of the global eye drops and lubricants market?
Who are the key players/companies in the global eye drops and lubricants market?

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Eye Drops and Lubricants Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Antibiotics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Hormones
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Artificial Tears
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Application
7.1 Eye Diseases
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Dry Eye
7.1.2.2 Glaucoma
7.1.2.3 Conjunctivitis
7.1.2.4 Refractive Errors
7.1.2.5 Others
7.1.3 Market Forecast
7.2 Eye Care
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
9.1 Overview
9.2 Drivers
9.3 Restraints
9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Akorn Operating Company LLC
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.2 Alcon
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.3 Allergan Plc (AbbVie Inc.)
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 SWOT Analysis
13.3.4 Bausch & Lomb Incorporated
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.5 Bayer AG
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Johnson & Johnson
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Maya Biotech Private Limited
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 Prestige Consumer Healthcare Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Rohto Pharmaceutical Co. Ltd.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.10 Sager Pharma Kft
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.11 Similasan Corporation
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio

*** 目薬＆潤滑剤の世界市場に関するよくある質問(FAQ) ***

・目薬＆潤滑剤の世界市場規模は？
→IMARC社は2024年の目薬＆潤滑剤の世界市場規模を213億米ドルと推定しています。

・目薬＆潤滑剤の世界市場予測は？
→IMARC社は2033年の目薬＆潤滑剤の世界市場規模を315億米ドルと予測しています。

・目薬＆潤滑剤市場の成長率は？
→IMARC社は目薬＆潤滑剤の世界市場が2025年～2033年に年平均4.2%成長すると展望しています。

・世界の目薬＆潤滑剤市場における主要プレイヤーは？
→「Akorn Operating Company LLC, Alcon, Allergan Plc (AbbVie Inc.), Bausch & Lomb Incorporated, Bayer AG, Johnson & Johnson, Maya Biotech Private Limited, Prestige Consumer Healthcare Inc., Rohto Pharmaceutical Co. Ltd., Sager Pharma Kft, Similasan Corporationなど ...」を目薬＆潤滑剤市場のグローバル主要プレイヤーとして判断しています。

※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/